Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy

NCT05962307 · clinicaltrials.gov ↗

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis D

Interventions

DRUG: Bulevirtide

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico